Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2026 08:00 ET | Source: RENEXXION IRELAND

Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026

Dr Falk and Renexxion selected for late-breaking oral presentation at this year’s DDW, for data from global P2b study of naronapride in gastroparesis.